A Collection of Representative Companies for Understanding Korean Bio Companies by Type
Collection Industrial Research 2026.07.20

A Collection of Representative Companies for Understanding Korean Bio Companies by Type

Comparing the different business models of companies like Samsung Biologics, Celltrion, SK Bioscience, Hanmi Pharmaceutical, and Yuhan Corporation

While domestic bio companies are often grouped under one term, their actual business models vary significantly. Some companies focus on contract manufacturing, others develop and sell biosimilars, while some grow based on vaccines, new drugs, anticancer drugs, platform technologies, and traditional pharmaceutical sales. Even the same bio news can be easily misunderstood without knowing the company's business model, which affects revenue structure and risks. This list summarizes representative companies that are helpful to understand domestic pharmaceutical and bio companies by type.

Samsung Biologics

Samsung Biologics is better understood as a CDMO company that produces biopharmaceuticals developed by global pharmaceutical companies, rather than a pharmaceutical company that sells new drugs directly. Its key competitive strengths are large-scale production facilities, quality management capabilities, and securing global clients. When looking at performance, the factory utilization rate, new contracts, production capacity expansion, and entry into new modalities are important.
기업 유형 바이오 CDMO
Visit

Celltrion

Celltrion is a representative company that has popularized the domestic bio industry through biosimilars. After the patent expiration of original biopharmaceuticals, it develops products that demonstrate similar effects and quality, competing in the global market. The biosimilar business is not only about licensing and production but also crucially involves overseas sales networks, price competition, and expanding prescriptions. It's important to consider new product launches and changes in the market share of existing products together.
기업 유형 바이오시밀러·바이오의약품
Visit

SK Bioscience

SK Bioscience is a notable company in the vaccine field. Vaccines are tied to public health, making the outbreak of infectious diseases, government procurement, global partnerships, and production facility certification very important. While the strategic value of vaccine production capacity has increased post-pandemic, it should also be noted that demand may fluctuate with the outbreak situation. It's advisable to distinguish between the pipeline and contract manufacturing agreements.
기업 유형 백신·바이오 생산
Visit

Hanmi Pharmaceutical

Hanmi Pharmaceutical is a company that has built research and development and technology export experience on a foundation of traditional pharmaceuticals. When reading pharmaceutical news, technology export contracts may appear as major positives, but it's essential to consider the contract amounts, milestones, the success of clinical trials, and the possibility of returns. For R&D-focused companies, the quality of the pipeline, clinical stages, and the partner's development commitment significantly impact corporate value.
기업 유형 연구개발 중심 제약사
Visit

Yuhan Corporation

Yuhan Corporation should be viewed through the lens of its long-established pharmaceutical sales base and its new drug development achievements. Companies with a stable pharmaceutical sales foundation can absorb some of the risks of research and development failures, and successful pipelines can become long-term growth engines. Looking at a comprehensive pharmaceutical company in terms of prescription drugs, over-the-counter drugs, technology exports, and partnerships provides a clearer view of its business structure.
기업 유형 종합 제약사·신약개발
Visit

Alteogen

Platform technology companies like Alteogen prioritize the range of technology applications and partnerships over specific finished product sales. Platform technologies have great potential for application across various medicines, but commercialization and royalties may take time to materialize. When evaluating related news, it’s important to check contract structures, applicable products, clinical stages, and the development progress of partners.
기업 유형 바이오 플랫폼 기술
Visit
When looking at bio companies, it's important to check how they earn money, what pipelines they have, and what stage of development they are in, rather than categorizing them broadly as 'growth stocks' just because they are in bio. Companies focused on production, new drug development, vaccines, and biosimilars have different revenue stability and risk of failure. Understanding the business model before the company name allows for a more composed reading of industry news and earnings reports.

As part of the Coupang Partners program, this post may earn a commission from qualifying purchases.

Comments 0

Log in to leave a comment.

Be the first to comment.

How about these lists?

You might also like

🎲

Not ready to stop here?

Wondering what to read next is the biggest waste of time.
Let the dice decide — you won't know what pops up until you roll.
If you don't press it… won't you wonder forever? 👀

All menu
Login required
Log in
Categories
Language
Display mode
✦ ✦ ✦ ✦ ✦

Drum roll… picking a list!

모하지
Use Mohazi as an app
Open it from your home screen and browse faster.
On iPhone, tap the Share button at the bottom of Safari, then choose “Add to Home Screen” to use it like an app.